Life Science Company News

Reset
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Novel Brain Stimulation Technique Shows Promise in Patients with Hard-to-Treat Depression

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023
Related companies:  Precigen, Inc.

PSG Biotech Launches New Quattroflow QB2-SD Single-Use Micropump

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Bovine Gelatin Market size to grow by USD 1.02 billion from 2022 to 2027, Bernard Jansen Products, Darling Ingredients Inc., El Nasr Gelatin Co., and more among key companies- Technavio

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Metastatic HER2-Positive Breast Cancer Market to Grow by 2032 at a 5.2% CAGR | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Public advisory - Unauthorized blood glucose (sugar)-reading smartwatches may pose serious health risks to people with diabetes

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023
Related companies:  Numinus Wellness Inc.

Nanalysis Reports Third Quarter 2023 Results

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023
Related companies:  Nanalysis Scientific Corp.

Movember Canada Closes The Market

Read more ››
By: PR Newswire Association LLC. - 29 Nov 2023

Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Cerevel Therapeutics Holdings, Inc.

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BiomX Inc.

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Generation Bio Co.

XORTX Meets Nasdaq Continued Listing Requirements

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  XORTX Therapeutics Inc

SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  SpringWorks Therapeutics Inc.

PreludeDx to Present Data for a Novel Molecular Biosignature to Predict Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer at the 2023 San Antonio Breast Cancer Symposium

Read more ››
By: GlobeNewswire - 29 Nov 2023

BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BioCardia, Inc.

Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Verge Genomics

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  BioCryst Pharmaceuticals, Inc.

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

Read more ››
By: GlobeNewswire - 29 Nov 2023
Related companies:  Athira Pharma, Inc.
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »